PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26220N0912BLOOD and BLOOD products for VA GLA

The incumbent holds $30.0M across 213 federal awards, concentrated at Department of Defense (DOD). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Aug 6, 2021 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

262-Network Contract Office 22 (36C262)

Awarding office

Aug 6, 2021

PoP end

$-7,412.45

Obligated

$531K

Potential

621991

NAICS

6505

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position — $90

Contract facts

NONE

Contract number36C26220N0912

Also listed as36C262-20-N-0912

Also listed asVA26216G0012-36C26220N0912

Agency262-Network Contract Office 22 (36C262)

Awarding office262-Network Contract Office 22 (36C262)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

CAGE0L9L2

UEIKLXGB46K7SL5

NAICS621991

No full NAICS 621991 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVVA26216G0012

Place of performanceLOS ANGELES CA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startAug 7, 2020

PoP end (current)Aug 6, 2021

Obligated$-7,412.45

Current value$531K

Potential value$531K

BLOOD AND BLOOD PRODUCTS FOR VA GLA is a federal NONE award for 262-Network Contract Office 22 (36C262). Estimated value $531K ($-7,412.45 obligated). Current period of performance ends Aug 6, 2021. Last award drew 1 bidder. Place of performance: LOS ANGELES CA.

Recompete timing

Public

● Past PoP end (1841 days ago)

Current PoP ended Aug 6, 2021 (1841 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Incumbent — $30.0M obligated across 213 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($30.0M) · all agencies · Top 2 shown (1%); remaining ~99% is other agencies.

Department of Defense (DOD)$294K · 1%Department of Veterans Affairs (VA)$146K · 0%

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C26220N0912?

36C26220N0912 (BLOOD and BLOOD products for VA GLA) is a 262-Network Contract Office 22 (36C262) award with a potential value of $531K. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C262-20-N-0912?

36C262-20-N-0912 is the dashed form of PIID 36C26220N0912 (BLOOD and BLOOD products for VA GLA). Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26220N0912?

262-Network Contract Office 22 (36C262) awarded 36C26220N0912 (potential $531K).

When does 36C26220N0912 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 6, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Nov 8, 2022